Phase II study of ABV (doxorubicin with increased dose, bleomycin and vinblastine) therapy in newly diagnosed advanced-stage Hodgkin lymphoma: Japan Clinical Oncology Group study (JCOG9705)
暂无分享，去创建一个
R. Ueda | M. Ogura | T. Kinoshita | K. Tobinai | K. Ishizawa | K. Itoh | K. Tsukasaki | Y. Morishima | T. Hotta | T. Shibata | M. Hirano | M. Shimoyama | S. Nakamura | Y. Kobayashi